#CRISPR

Last 30 Days 📈 Bullish 📈1

Release 📈 Stocks

ERS Genomics Grants CRISPR/Cas9 Licensing Rights to KU Leuven

October 22, 2026 (12 days ago)

ERS Genomics expands its CRISPR licensing footprint by providing KU Leuven's Viral Vector Core with essential intellectual property to advance global genome…

ERS Genomics KU Leuven

🌍 EUROPE Read More →

News 📈 Stocks

Eli Lilly-Backed Scribe Therapeutics Soars 50% After Upsized IPO

July 24, 2026 (102 days ago)

Eli Lilly-backed biotech Scribe Therapeutics jumps 50% after upsized IPO, signaling renewed biotech IPO momentum.

SCRI LLY

🌍 US Read More →